Literature DB >> 9572918

Solid state characterization of spray-dried powders of recombinant human deoxyribonuclease (rhDNase).

H K Chan1, I Gonda.   

Abstract

rhDNase is a recombinant human protein approved as an aqueous solution for human use by inhalation. To study the feasibility of preparation of dry powders for inhalation, spray-dried powders of pure rhDNase and co-spray-dried mixtures of rhDNase with an excipient approved for inhalation products, lactose, were prepared. Both types of powders were initially amorphous. The lactose, however, was found to crystallize after exposure to a humid environment. The crystals in the powder were identified as the alpha-monohydrate polymorph of lactose by hot-stage optical and scanning electron microscopy, differential scanning calorimetry and thermogravimetry, FTIR spectroscopy, and X-ray powder diffraction. Moisture sorption isotherms indicated that crystallization occurred at high relative humidities (70-85%), depending on the temperature of the environment (5-40 degreesC). The practical implications for the manufacturing and storage of protein powders for inhalation are discussed.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9572918     DOI: 10.1021/js9504292

Source DB:  PubMed          Journal:  J Pharm Sci        ISSN: 0022-3549            Impact factor:   3.534


  5 in total

1.  Development of a mathematical model for the water distribution in freeze-dried solids.

Authors:  H K Chan; K L Au-Yeung; I Gonda
Journal:  Pharm Res       Date:  1999-05       Impact factor: 4.200

2.  Generation of fine powders of recombinant human deoxyribonuclease using the aerosol solvent extraction system.

Authors:  Rana T Bustami; Hak-Kim Chan; Theresa Sweeney; Fariba Dehghani; Neil R Foster
Journal:  Pharm Res       Date:  2003-12       Impact factor: 4.200

Review 3.  Pharmaceutical particle engineering via spray drying.

Authors:  Reinhard Vehring
Journal:  Pharm Res       Date:  2007-11-28       Impact factor: 4.200

4.  Influence of particle size, air flow, and inhaler device on the dispersion of mannitol powders as aerosols.

Authors:  N Y Chew; H K Chan
Journal:  Pharm Res       Date:  1999-07       Impact factor: 4.200

Review 5.  Inhalation delivery technology for genome-editing of respiratory diseases.

Authors:  Michael Y T Chow; Rachel Yoon Kyung Chang; Hak-Kim Chan
Journal:  Adv Drug Deliv Rev       Date:  2020-06-05       Impact factor: 15.470

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.